Functional, Biophysical, and Structural Characterization of Human IgG1 and IgG4 Fc Variants with Ablated Immune Functionality

Tam, Susan H.; McCarthy, Stephen G.; Armstrong, Anthony A.; Somani, Sandeep; Wu, Sheng-Jiun; Liu, Xuesong; Gervais, Alexis; Ernst, Robin; Saro, Dorina; Decker, Rose; Luo, Jinquan; Gilliland, Gary L.; Chiu, Mark L.; Scallon, Bernard J.

doi:10.3390/antib6030012

Functional, Biophysical, and Structural Characterization of Human IgG1 and IgG4 Fc Variants with Ablated Immune Functionality

Journal Article · Fri Sep 01 04:00:00 EDT 2017 · Antibodies

DOI:https://doi.org/10.3390/antib6030012· OSTI ID:1504981

Tam, Susan H.; McCarthy, Stephen G.; Armstrong, Anthony A.; Somani, Sandeep; Wu, Sheng-Jiun; Liu, Xuesong; Gervais, Alexis; Ernst, Robin; Saro, Dorina; Decker, Rose; Luo, Jinquan; Gilliland, Gary L.; Chiu, Mark L.; Scallon, Bernard J. ^[1]

Janssen

Abstract not provided

Research Organization:: Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)

Sponsoring Organization:: INDUSTRY

Contributing Organization:: Susan Tam; Stephen McCarthy; Anthony Armstrong; Sandeep Somani; Sheng-Jiun Wu; Xuesong Liu; Alexis Gervais; Robin Ernst; Dorina Saro; Rose Decker; Jinquan Luo; Gary Gilliland; Mark Chiu; Bernard Scallon

OSTI ID:: 1504981

Journal Information:: Antibodies, Journal Name: Antibodies Journal Issue: 3 Vol. 6; ISSN ANTICA; ISSN 2073-4468

Country of Publication:: United States

Language:: ENGLISH

References (71)

Structural and Functional Characterization of Disulfide Isoforms of the Human IgG2 Subclass Dillon, Thomas M.; Ricci, Margaret Speed; Vezina, Chris Journal of Biological Chemistry, Vol. 283, Issue 23 https://doi.org/10.1074/jbc.M709988200	journal	March 2008
Genetically Engineered Humanized Mouse Models for Preclinical Antibody Studies Proetzel, Gabriele; Wiles, Michael V.; Roopenian, Derry C. BioDrugs, Vol. 28, Issue 2 https://doi.org/10.1007/s40259-013-0071-0	journal	October 2013
Dose-escalation of human anti-interferon-α receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study Goldberg, Avram; Geppert, Thomas; Schiopu, Elena Arthritis Research & Therapy, Vol. 16, Issue 1 https://doi.org/10.1186/ar4492	journal	January 2014
Crystal structure of deglycosylated human IgG4-Fc Davies, Anna M.; Jefferis, Roy; Sutton, Brian J. Molecular Immunology, Vol. 62, Issue 1 https://doi.org/10.1016/j.molimm.2014.05.015	journal	November 2014
The High-Affinity IgG Receptor, FcγRI, Plays a Central Role in Antibody Therapy of Experimental Melanoma Bevaart, Lisette; Jansen, Marco J. H.; van Vugt, Martine J. Cancer Research, Vol. 66, Issue 3 https://doi.org/10.1158/0008-5472.CAN-05-2856	journal	February 2006
IgG2 Fc structure and the dynamic features of the IgG CH2–CH3 interface Teplyakov, Alexey; Zhao, Yonghong; Malia, Thomas J. Molecular Immunology, Vol. 56, Issue 1-2 https://doi.org/10.1016/j.molimm.2013.03.018	journal	November 2013
High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR Shields, Robert L.; Namenuk, Angela K.; Hong, Kyu Journal of Biological Chemistry, Vol. 276, Issue 9 https://doi.org/10.1074/jbc.M009483200	journal	November 2000
Quantitative in vivo comparisons of the Fcγ receptor-dependent agonist activities of different fucosylation variants of an immunoglobulin G antibody Scallon, Bernard; McCarthy, Stephen; Radewonuk, Jennifer International Immunopharmacology, Vol. 7, Issue 6 https://doi.org/10.1016/j.intimp.2007.01.014	journal	June 2007
Replica exchange with solute tempering: A method for sampling biological systems in explicit water Liu, P.; Kim, B.; Friesner, R. A. Proceedings of the National Academy of Sciences, Vol. 102, Issue 39 https://doi.org/10.1073/pnas.0506346102	journal	September 2005
FcRn: the neonatal Fc receptor comes of age Roopenian, Derry C.; Akilesh, Shreeram Nature Reviews Immunology, Vol. 7, Issue 9 https://doi.org/10.1038/nri2155	journal	August 2007
PHENIX: a comprehensive Python-based system for macromolecular structure solution Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221 https://doi.org/10.1107/S0907444909052925	journal	January 2010
IgG2m4, an engineered antibody isotype with reduced Fc function An, Zhiqiang; Forrest, Gail; Moore, Renee mAbs, Vol. 1, Issue 6 https://doi.org/10.4161/mabs.1.6.10185	journal	November 2009
The Covalent Structure of an Entire g Immunoglobulin Molecule Edelman, G. M.; Cunningham, B. A.; Gall, W. E. Proceedings of the National Academy of Sciences, Vol. 63, Issue 1 https://doi.org/10.1073/pnas.63.1.78	journal	May 1969
Engineering an IgG Scaffold Lacking Effector Function with Optimized Developability Jacobsen, Frederick W.; Stevenson, Riki; Li, Cynthia Journal of Biological Chemistry, Vol. 292, Issue 5 https://doi.org/10.1074/jbc.M116.748525	journal	December 2016
Fcγ Receptors: Old Friends and New Family Members Nimmerjahn, Falk; Ravetch, Jeffrey V. Immunity, Vol. 24, Issue 1 https://doi.org/10.1016/j.immuni.2005.11.010	journal	January 2006
Fc‐fusion proteins: new developments and future perspectives Czajkowsky, Daniel M.; Hu, Jun; Shao, Zhifeng EMBO Molecular Medicine, Vol. 4, Issue 10 https://doi.org/10.1002/emmm.201201379	journal	July 2012
Phaser crystallographic software McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D. Journal of Applied Crystallography, Vol. 40, Issue 4 https://doi.org/10.1107/S0021889807021206	journal	July 2007
Regulation of Antibody Production Mediated by Fcγ Receptors, IgG Binding Factors, and IgG Fc-Binding Autoantibodies Gergely, Janos; Sarmay, Gabriella; Rajnavulgyi, Eava Critical Reviews in Biochemistry and Molecular Biology, Vol. 27, Issue 3 https://doi.org/10.3109/10409239209082563	journal	January 1992
A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody Angal, S.; King, D. J.; Bodmer, M. W. Molecular Immunology, Vol. 30, Issue 1 https://doi.org/10.1016/0161-5890(93)90432-B	journal	January 1993
With or Without Sugar? (A)glycosylation of Therapeutic Antibodies Hristodorov, Dmitrij; Fischer, Rainer; Linden, Lars Molecular Biotechnology, Vol. 54, Issue 3 https://doi.org/10.1007/s12033-012-9612-x	journal	October 2012
A broad range of Fab stabilities within a host of therapeutic IgGs Garber, Ellen; Demarest, Stephen J. Biochemical and Biophysical Research Communications, Vol. 355, Issue 3 https://doi.org/10.1016/j.bbrc.2007.02.042	journal	April 2007
Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc RIII and antibodies lacking core fucose Ferrara, C.; Grau, S.; Jager, C. Proceedings of the National Academy of Sciences, Vol. 108, Issue 31 https://doi.org/10.1073/pnas.1108455108	journal	July 2011
In Vitro Characterization of Five Humanized OKT3 Effector Function Variant Antibodies Xu, Danlin; Alegre, Maria-Luisa; Varga, Sally S. Cellular Immunology, Vol. 200, Issue 1 https://doi.org/10.1006/cimm.2000.1617	journal	February 2000
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins Harder, Edward; Damm, Wolfgang; Maple, Jon Journal of Chemical Theory and Computation, Vol. 12, Issue 1 https://doi.org/10.1021/acs.jctc.5b00864	journal	December 2015
Optimization of Fc-mediated effector functions of monoclonal antibodies Strohl, William R. Current Opinion in Biotechnology, Vol. 20, Issue 6 https://doi.org/10.1016/j.copbio.2009.10.011	journal	December 2009
Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists Scallon, Bernie; Cai, Ann; Solowski, Nancy Journal of Pharmacology and Experimental Therapeutics, Vol. 301, Issue 2 https://doi.org/10.1124/jpet.301.2.418	journal	May 2002
Intravenous immunoglobulins induce CD32-mediated platelet aggregation in vitro Pollreisz, A.; Assinger, A.; Hacker, S. British Journal of Dermatology, Vol. 159, Issue 3 https://doi.org/10.1111/j.1365-2133.2008.08700.x	journal	September 2008
Structural Determinants of Unique Properties of Human IgG4-Fc Davies, Anna M.; Rispens, Theo; Ooijevaar-de Heer, Pleuni Journal of Molecular Biology, Vol. 426, Issue 3 https://doi.org/10.1016/j.jmb.2013.10.039	journal	February 2014
F c RECEPTOR BIOLOGY Daëron, Marc Annual Review of Immunology, Vol. 15, Issue 1 https://doi.org/10.1146/annurev.immunol.15.1.203	journal	April 1997
Fc Optimization of Therapeutic Antibodies Enhances Their Ability to Kill Tumor Cells In vitro and Controls Tumor Expansion In vivo via Low-Affinity Activating Fc Receptors Stavenhagen, J. B.; Gorlatov, S.; Tuaillon, N. Cancer Research, Vol. 67, Issue 18 https://doi.org/10.1158/0008-5472.CAN-07-0696	journal	September 2007
Fcγ receptors as regulators of immune responses Nimmerjahn, Falk; Ravetch, Jeffrey V. Nature Reviews Immunology, Vol. 8, Issue 1 https://doi.org/10.1038/nri2206	journal	January 2008
Overview of the CCP 4 suite and current developments Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D. Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4 https://doi.org/10.1107/S0907444910045749	journal	March 2011
Engineered antibody Fc variant with selectively enhanced Fc RIIb binding over both Fc RIIaR131 and Fc RIIaH131 Mimoto, F.; Katada, H.; Kadono, S. Protein Engineering Design and Selection, Vol. 26, Issue 10 https://doi.org/10.1093/protein/gzt022	journal	June 2013
Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions Schlothauer, Tilman; Herter, Sylvia; Koller, Claudia Ferrara Protein Engineering Design and Selection, Vol. 29, Issue 10 https://doi.org/10.1093/protein/gzw040	journal	August 2016
Structural basis for binding of human IgG1 to its high-affinity human receptor FcγRI Kiyoshi, Masato; Caaveiro, Jose M. M.; Kawai, Takeaki Nature Communications, Vol. 6, Issue 1 https://doi.org/10.1038/ncomms7866	journal	April 2015
The antiinflammatory activity of IgG: the intravenous IgG paradox Nimmerjahn, Falk; Ravetch, Jeffrey V. The Journal of Experimental Medicine, Vol. 204, Issue 1 https://doi.org/10.1084/jem.20061788	journal	January 2007
Optimizing engagement of the immune system by anti-tumor antibodies: an engineer's perspective Desjarlais, John R.; Lazar, Greg A.; Zhukovsky, Eugene A. Drug Discovery Today, Vol. 12, Issue 21-22 https://doi.org/10.1016/j.drudis.2007.08.009	journal	November 2007
A Non-Activating “Humanized” Anti-Cd3 Monoclonal Antibody Retains Immunosuppressive Properties in vivo Alegre, Maria-Luisa; Peterson, Laura J.; Xu, Danlin Transplantation, Vol. 57, Issue 11 https://doi.org/10.1097/00007890-199457110-00001	journal	January 1994
Mouse model recapitulating human Fc receptor structural and functional diversity Smith, P.; DiLillo, D. J.; Bournazos, S. Proceedings of the National Academy of Sciences, Vol. 109, Issue 16 https://doi.org/10.1073/pnas.1203954109	journal	April 2012
Identification of the Fc gamma receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies. Chappel, M. S.; Isenman, D. E.; Everett, M. Proceedings of the National Academy of Sciences, Vol. 88, Issue 20 https://doi.org/10.1073/pnas.88.20.9036	journal	October 1991
Understanding the relevance of local conformational stability and dynamics to the aggregation propensity of an IgG1 and IgG2 monoclonal antibodies: Local Conformational Stability, Dynamics and Aggregation Propensity of mAbs Thakkar, Santosh V.; Sahni, Neha; Joshi, Sangeeta B. Protein Science, Vol. 22, Issue 10 https://doi.org/10.1002/pro.2316	journal	August 2013
Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin Gautam, A.; Waldrep, J. C.; Densmore, C. L. Gene Therapy, Vol. 9, Issue 5 https://doi.org/10.1038/sj.gt.3301662	journal	March 2002
Coot model-building tools for molecular graphics Emsley, Paul; Cowtan, Kevin Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132 https://doi.org/10.1107/S0907444904019158	journal	November 2004
Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions Scallon, B. Cytokine, Vol. 7, Issue 3 https://doi.org/10.1006/cyto.1995.0029	journal	April 1995
Clinical chemistry of human FcRn transgenic mice Stein, Carsten; Kling, Lothar; Proetzel, Gabriele Mammalian Genome, Vol. 23, Issue 3-4 https://doi.org/10.1007/s00335-011-9379-6	journal	December 2011
XDS Kabsch, Wolfgang Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2 https://doi.org/10.1107/S0907444909047337	journal	January 2010
Human IgG2 Antibodies Display Disulfide-mediated Structural Isoforms Wypych, Jette; Li, Ming; Guo, Amy Journal of Biological Chemistry, Vol. 283, Issue 23 https://doi.org/10.1074/jbc.M709987200	journal	March 2008
Immunoglobulin isotype knowledge and application to Fc engineering Brezski, Randall J.; Georgiou, George Current Opinion in Immunology, Vol. 40 https://doi.org/10.1016/j.coi.2016.03.002	journal	June 2016
Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters Strohl, William R. BioDrugs, Vol. 29, Issue 4 https://doi.org/10.1007/s40259-015-0133-6	journal	July 2015
phenix.model_vs_data : a high-level tool for the calculation of crystallographic model and data statistics Afonine, Pavel V.; Grosse-Kunstleve, Ralf W.; Chen, Vincent B. Journal of Applied Crystallography, Vol. 43, Issue 4 https://doi.org/10.1107/S0021889810015608	journal	May 2010
Asymmetric Fc Engineering for Bispecific Antibodies with Reduced Effector Function Escobar-Cabrera, Eric; Lario, Paula; Baardsnes, Jason Antibodies, Vol. 6, Issue 2 https://doi.org/10.3390/antib6020007	journal	May 2017
Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange Labrijn, A. F.; Meesters, J. I.; de Goeij, B. E. C. G. Proceedings of the National Academy of Sciences, Vol. 110, Issue 13 https://doi.org/10.1073/pnas.1220145110	journal	March 2013
Engineered antibody Fc variants with enhanced effector function Lazar, G. A.; Dang, W.; Karki, S. Proceedings of the National Academy of Sciences, Vol. 103, Issue 11 https://doi.org/10.1073/pnas.0508123103	journal	March 2006
An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations Vafa, Omid; Gilliland, Gary L.; Brezski, Randall J. Methods, Vol. 65, Issue 1 https://doi.org/10.1016/j.ymeth.2013.06.035	journal	January 2014
Humanized FcRn mouse models for evaluating pharmacokinetics of human IgG antibodies Proetzel, Gabriele; Roopenian, Derry C. Methods, Vol. 65, Issue 1 https://doi.org/10.1016/j.ymeth.2013.07.005	journal	January 2014
Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses Bruhns, Pierre; Iannascoli, Bruno; England, Patrick Blood, Vol. 113, Issue 16 https://doi.org/10.1182/blood-2008-09-179754	journal	April 2009
The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of γ-globulin in humans Firan, Mihail; Bawdon, Roger; Radu, Caius International Immunology, Vol. 13, Issue 8 https://doi.org/10.1093/intimm/13.8.993	journal	August 2001
Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors Sazinsky, S. L.; Ott, R. G.; Silver, N. W. Proceedings of the National Academy of Sciences, Vol. 105, Issue 51 https://doi.org/10.1073/pnas.0809257105	journal	December 2008
Structural characterization of a human Fc fragment engineered for lack of effector functions Oganesyan, Vaheh; Gao, Changshou; Shirinian, Lena Acta Crystallographica Section D Biological Crystallography, Vol. 64, Issue 6 https://doi.org/10.1107/S0907444908007877	journal	May 2008
Fc Receptors Ravetch, J. V.; Kinet, J. P. Annual Review of Immunology, Vol. 9, Issue 1 https://doi.org/10.1146/annurev.iy.09.040191.002325	journal	April 1991
Humanized porcine VCAM-specific monoclonal antibodies with chimeric IgG2/G4 constant regions block human leukocyte binding to porcine endothelial cells Mueller, John P.; Giannoni, Michelle A.; Hartman, Sandra L. Molecular Immunology, Vol. 34, Issue 6 https://doi.org/10.1016/S0161-5890(97)00042-4	journal	April 1997
Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding Nimmerjahn, F. Science, Vol. 310, Issue 5753 https://doi.org/10.1126/science.1118948	journal	December 2005
HuM291, A HUMANIZED ANTI-CD3 ANTIBODY, IS IMMUNOSUPPRESSIVE TO T CELLS WHILE EXHIBITING REDUCED MITOGENICITY IN VITRO1 Cole, Michael S.; Stellrecht, Karl E.; Shi, Jia D. Transplantation, Vol. 68, Issue 4 https://doi.org/10.1097/00007890-199908270-00020	journal	January 1999
When binding is enough: nonactivating antibody formats Labrijn, Aran F.; Aalberse, Rob C.; Schuurman, Janine Current Opinion in Immunology, Vol. 20, Issue 4 https://doi.org/10.1016/j.coi.2008.05.010	journal	August 2008
Bispecific antibodies Kontermann, Roland E.; Brinkmann, Ulrich Drug Discovery Today, Vol. 20, Issue 7 https://doi.org/10.1016/j.drudis.2015.02.008	journal	July 2015
Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein Hara, I. Journal of Experimental Medicine, Vol. 182, Issue 5 https://doi.org/10.1084/jem.182.5.1609	journal	November 1995
Human FcRn Transgenic Mice for Pharmacokinetic Evaluation of Therapeutic Antibodies Roopenian, Derry C.; Christianson, Gregory J.; Sproule, Thomas J. Methods in Molecular Biology https://doi.org/10.1007/978-1-60761-058-8_6	book	November 2006
Structural Comparison of Fucosylated and Nonfucosylated Fc Fragments of Human Immunoglobulin G1 Matsumiya, Shigeki; Yamaguchi, Yoshiki; Saito, Jun-ichi Journal of Molecular Biology, Vol. 368, Issue 3 https://doi.org/10.1016/j.jmb.2007.02.034	journal	May 2007
Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates Stubenrauch, Kay; Wessels, Uwe; Lenz, Helmut Journal of Pharmaceutical and Biomedical Analysis, Vol. 49, Issue 4 https://doi.org/10.1016/j.jpba.2009.01.030	journal	May 2009
IMGT, the international ImMunoGeneTics database Lefranc, M. -P.; Giudicelli, V.; Ginestoux, C. Nucleic Acids Research, Vol. 27, Issue 1 https://doi.org/10.1093/nar/27.1.209	journal	January 1999
Anti-tumor activity of human IgG1 anti-gp75 TA99 mAb against B16F10 melanoma in human FcgammaRI transgenic mice Boross, Peter; Jansen, J. H. Marco; van Tetering, Geert Immunology Letters, Vol. 160, Issue 2 https://doi.org/10.1016/j.imlet.2014.02.005	journal	August 2014

Similar Records

Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1s

Journal Article · Wed Jan 05 19:00:00 EST 2022 · Frontiers in Immunology · OSTI ID:2469866

Structural insights into the interaction of human IgG1 with Fc[gamma]RI: no direct role of glycans in binding

Journal Article · Sun Nov 22 23:00:00 EST 2015 · Acta Crystallographica. Section D. Structural Biology · OSTI ID:1225741

Generation and Characterization of an IgG4 Monomeric Fc Platform

Journal Article · Sun Jul 31 20:00:00 EDT 2016 · PLoS ONE · OSTI ID:1438919

Functional, Biophysical, and Structural Characterization of Human IgG1 and IgG4 Fc Variants with Ablated Immune Functionality

Citation Formats

References (71)

Similar Records

Related Subjects